Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) shares fell -4.53% in last trading session and ended the day at $4.00. IMMY Gross Margin is 47.10% and its has a return on assets of -104.90%. Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) quarterly performance is -26.47%.
On 10 February, Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, announced plans to introduce new patent-pending tiopronin and potassium citrate delayed release (DR) compounded formulations that may be prescribed by physicians as a lower cost therapeutic alternative to FDA-approved Thiola. The formulations are expected to be available to prescribers in April 2016.
HEICO Corporation (NYSE:HEI-A) ended the last trading day at $41.04. Company weekly volatility is calculated as 2.84%. HEICO Corporation (NYSE:HEI-A) showed a weekly performance of -2.22%.
On February 25, 2016, after the NYSE closing, HEICO Corporation (NYSE:HEI-A) (HEI) will release its financial results for the first quarter ended January 31, 2016.
On 18 February, BHP Billiton plc (NYSE:BBL) shares fell -0.05% and was closed at $21.33. BBL EPS growth in last 5 year was -22.40%. BHP Billiton plc (NYSE:BBL) year to date (YTD) performance is -5.83%.
On 10 February, BHP Billiton plc (NYSE:BBL) and SaskPower have signed an agreement to establish the BHP Billiton SaskPower carbon capture knowledge center to help advance carbon capture and storage, or CCS, as a means of managing greenhouse gas emissions.
Ardelyx, Inc. (NASDAQ:ARDX) shares fell -7.19% in last trading session and ended the day at $10.45. ARDX its has a return on assets of -12.50%. Ardelyx, Inc. (NASDAQ:ARDX) quarterly performance is -42.46%.
Ardelyx, Inc. (NASDAQ:ARDX), announced that Mike Raab, President and Chief Executive Officer, and David Rosenbaum, Ph.D., Senior Vice President of Drug Development, participated in the 2016 Leerink Partners Global Healthcare Conference at 3:05 p.m. EST on Wednesday, February 10, 2016 at the Waldorf Astoria in New York City.
NantKwest, Inc. (NASDAQ:NK) caters to the Healthcare space. Its weekly performance is 17.92%. On the last day of trading company shares ended up at $7.50. NantKwest, Inc. (NASDAQ:NK) distance from 50-day simple moving average (SMA50) is 55.12%.
FBR & Co. reiterated their buy rating on shares of Nantkwest Inc (NYSE:NK) in a research report report published on Friday morning, MarketBeat reports.
Leave a Reply